Starpharma Holdings
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAStarpharma Holdings (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications.
Its underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses.
SPL has two core development programs: VivaGel portfolio and DEP drug delivery.
Contact Details
4-6 Southampton Crescent, ABBOTSFORD VIC 3067
03 8532 2700
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1279th | Starpharma Holdings | -30% | -40% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Starpharma Holdings | $8.3m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Cheryl Maley, Chief Executive Officer, Managing Director | 08 Aug 2024 |
| NEW ROLE: Jeff Davies, Non-Executive Director | 08 Aug 2024 |
| NEW ROLE: Russell Basser, Non-Executive Director | 08 Aug 2024 |
| NEW ROLE: Lynda Cheng, Non-Executive Director | 18 Mar 2022 |
| NEW ROLE: A Eglezos, | 25 Nov 2020 |
| NEW ROLE: J R Paull, Corporate Affairs | 25 Nov 2020 |
| NEW ROLE: D J Owen, Vice President-Research | 24 Nov 2020 |
| NEW ROLE: Richard Hazelton, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Nigel Baade, Chief Financial Officer, Company Secretary since 2013 | 03 Nov 2020 |
